<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="mfm" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">mfm</book-part-id>
      <title-group>
        <title>Myofibrillar Myopathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Selcen</surname>
            <given-names>Duygu</given-names>
          </name>
          <xref ref-type="aff" rid="mfm.AFF1"/>
          <degrees>MD</degrees>
          <email>Selcen.Duygu@mayo.edu</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Engel</surname>
            <given-names>Andrew G</given-names>
          </name>
          <xref ref-type="aff" rid="mfm.AFF2"/>
          <degrees>MD</degrees>
          <email>age@mayo.edu</email>
        </contrib>
      </contrib-group>
      <aff id="mfm.AFF1">Department of Neurology and Neuromuscular Research Laboratory <break/>Mayo Clinic<break/>Rochester, Minnesota</aff>
      <aff id="mfm.AFF2">Department of Neurology and Neuromuscular Research Laboratory <break/>Mayo Clinic<break/>Rochester, Minnesota</aff>
      <pub-history>
        <date iso-8601-date="2005-01-28" date-type="created">
          <day>28</day>
          <month>01</month>
          <year>2005</year>
        </date>
        <date iso-8601-date="2012-10-29" date-type="updated">
          <day>29</day>
          <month>10</month>
          <year>2012</year>
        </date>
        <date iso-8601-date="2010-07-27" date-type="revised">
          <day>27</day>
          <month>07</month>
          <year>2010</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="myo-dystonia" document-type="chapter">Myoclonus-Dystonia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="myodef-sda" document-type="chapter">Myopathy with Deficiency of ISCU</related-object>
      <abstract id="mfm.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Myofibrillar myopathy is characterized by slowly progressive weakness that can involve both proximal and distal muscles. Distal muscle weakness is present in about 80% of individuals and is more pronounced than proximal weakness in about 25%. A minority of individuals experience sensory symptoms, muscle stiffness, aching, or cramps. Peripheral neuropathy is present in about 20% of affected individuals. Overt cardiomyopathy is present in 15%-30%.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of myofibrillar myopathy is based on clinical findings, electromyography (EMG), nerve conduction studies, and, most importantly, muscle histology. To date, the genetic basis of myofibrillar myopathy has been elucidated in only about 50% of cases. Mutations have been identified in <italic toggle="yes">DES</italic>, the gene encoding desmin; <italic toggle="yes">CRYAB</italic>, encoding alpha-crystallin B chain; <italic toggle="yes">MYOT</italic>, encoding myotilin; <italic toggle="yes">LDB3</italic> (<italic toggle="yes">ZASP</italic>), encoding LIM domain-binding protein 3; <italic toggle="yes">FLNC</italic>, encoding filamin-C, and <italic toggle="yes">BAG3</italic>, encoding BAG family molecular chaperone regulator 3. Recently, mutations in <italic toggle="yes">FHL1,</italic> encoding four and a half LIM domains protein 1, and <italic toggle="yes">DNAJB6</italic>, encoding DnaJ homolog subfamily B member 6 were also identified.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Consider pacemaker and implantable cardioverter defibrillator (ICD) in individuals with arrhythmia and/or cardiac conduction defects; consider cardiac transplantation in individuals with progressive or life-threatening cardiomyopathy; respiratory support (continuous or bilevel positive airway pressure), initially at night and later in the daytime, in individuals with hypercapnea and other signs of incipient respiratory failure; range-of-motion physical therapy and assistive devices for those with advanced muscle weakness. </p>
          <p><italic toggle="yes">Other:</italic> The role of strengthening exercises has not been defined.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Myofibrillar myopathy is most commonly inherited in an autosomal dominant manner. Exceptions include: x-linked inheritance of <italic toggle="yes">FHL1</italic> mutations and autosomal recessive inheritance of <italic toggle="yes">CRYAB</italic> frameshift mutations that lead to premature termination of the translational chain resulting in non-transcription of the mutant protein. The inheritance in some families cannot be determined with confidence. When the disease-causing mutation in the family is known, carrier testing and prenatal testing for pregnancies at increased risk is possible.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="mfm.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="mfm.T.nc_myofibrillar_myopathy_included_" position="anchor" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <th id="hd_b_mfm.T.nc_myofibrillar_myopathy_included__1_1_1_1" align="left" valign="top" rowspan="1" colspan="1">Myofibrillar Myopathy: Included Disorders</th>
              </tr>
              <tr>
                <td headers="hd_b_mfm.T.nc_myofibrillar_myopathy_included__1_1_1_1" align="left" valign="top" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Alpha-B crystallinopathy</p>
                    </list-item>
                    <list-item>
                      <p><italic toggle="yes">BAG3</italic>-related myofibrillar myopathy</p>
                    </list-item>
                    <list-item>
                      <p>Desminopathy</p>
                    </list-item>
                    <list-item>
                      <p><italic toggle="yes">DNAJB6</italic>-related myofibrillar myopathy</p>
                    </list-item>
                    <list-item>
                      <p><italic toggle="yes">FHL1</italic>-related myofibrillar myopathy</p>
                    </list-item>
                    <list-item>
                      <p>Filaminopathy</p>
                    </list-item>
                    <list-item>
                      <p>Myotilinopathy</p>
                    </list-item>
                    <list-item>
                      <p>Zaspopathy</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="mfm.TF.1">
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="mfm.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="mfm.Diagnosis">
        <title>Diagnosis</title>
        <sec id="mfm.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The term myofibrillar myopathy refers to a group of genetically distinct disorders linked by common morphologic features observed on muscle histology.</p>
          <p>The diagnosis of myofibrillar myopathy rests on the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>History of slowly progressive weakness</bold> accompanied in a smaller proportion of individuals by paresthesias, muscle atrophy, stiffness or aching, cramps, dyspnea, and dysphagia. Physical examination reveals proximal and distal weakness in the majority of individuals. In about one third the weakness is greater proximally than distally; in another third it is greater distally than proximally. Facial weakness is uncommon but can occur. Tendon reflexes are normal or diminished.</p>
            </list-item>
            <list-item>
              <p><bold>Electromyography</bold> (EMG) that reveals abnormal electrical irritability (fibrillation potentials, positive sharp waves, complex repetitive discharges, and myotonic discharges) in most individuals. The motor unit potentials show either myopathic features or both myopathic and neurogenic features. Abnormal nerve conduction studies are detected in about 20% of individuals.</p>
            </list-item>
            <list-item>
              <p><bold>Muscle histology</bold> that reveals the following combination of findings (see <xref ref-type="fig" rid="mfm.F1">Figure 1</xref>): </p>
              <list list-type="bullet">
                <list-item>
                  <p>Characteristic alterations in trichromatically stained frozen sections consisting of amorphous, hyaline, or granular material in a variable proportion of the muscle fibers; </p>
                </list-item>
                <list-item>
                  <p>Sharply circumscribed decreases of oxidative enzyme activity in many abnormal fiber regions; </p>
                </list-item>
                <list-item>
                  <p>Intense congophilia of many hyaline structures, best observed under rhodamine fluorescence optics; and </p>
                </list-item>
                <list-item>
                  <p>Small vacuoles in a variable number of fibers</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Immunocytochemical studies of muscle</bold> that show abnormal ectopic expression of myotilin (90% of abnormal fibers), desmin (75%), &#x003b1;-B crystallin (75%), dystrophin (70%), and &#x003b2;-amyloid precursor protein (70%)</p>
            </list-item>
            <list-item>
              <p><bold>Electron microscopy of muscle</bold> showing progressive myofibrillar degeneration commencing at the Z-disk, disintegration of the sarcomeres, accumulation of degraded filamentous material in pleomorphic hyaline inclusions, and dislocation of membranous organelles and their degradation in autophagic vacuoles [<xref ref-type="bibr" rid="mfm.REF.selcen.2004.439">Selcen et al 2004</xref>]</p>
            </list-item>
            <list-item>
              <p>
                <bold>Other tissues</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Peripheral nerve biopsies, in a few descriptions, show accumulation of neurofilaments, neurotubules, and formation of axonal spheroids.</p>
                </list-item>
                <list-item>
                  <p>Myocardial biopsies show desmin-immunoreactive cytoplasmic inclusions, especially near intercalated disks and interstitial fibrosis. </p>
                </list-item>
                <list-item>
                  <p>Peripheral nerve pathology [<xref ref-type="bibr" rid="mfm.REF.sabatelli.1992.1">Sabatelli et al 1992</xref>] and myocardial pathology [<xref ref-type="bibr" rid="mfm.REF.abraham.1998.876">Abraham et al 1998</xref>, <xref ref-type="bibr" rid="mfm.REF.arbustini.1998.645">Arbustini et al 1998</xref>, <xref ref-type="bibr" rid="mfm.REF.lobrinus.1998.77">Lobrinus et al 1998</xref>] have been described briefly in a small number of individuals with myofibrillar myopathy.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Serum creatine kinase concentration</bold> can be normal or elevated to no greater than seven times the upper limit of normal.</p>
            </list-item>
          </list>
        </sec>
        <sec id="mfm.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Genes.</bold> To date, the genetic basis of myofibrillar myopathy (MFM) has been elucidated in about 50% of kinships. Mutations have been identified in the following genes:</p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">DES</italic>, encoding desmin [<xref ref-type="bibr" rid="mfm.REF.goldfarb.1998.402">Goldfarb et al 1998</xref>, <xref ref-type="bibr" rid="mfm.REF.munozmarmol.1998.11312">Munoz-Marmol et al 1998</xref>, <xref ref-type="bibr" rid="mfm.REF.dalakas.2000.770">Dalakas et al 2000</xref>]</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">CRYAB</italic>, encoding &#x003b1;-crystallin B chain [<xref ref-type="bibr" rid="mfm.REF.vicart.1998.92">Vicart et al 1998</xref>, <xref ref-type="bibr" rid="mfm.REF.selcen.2003.804">Selcen &#x00026; Engel 2003</xref>]</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">MYOT</italic> (known previously as <italic toggle="yes">TTID</italic>), encoding myotilin [<xref ref-type="bibr" rid="mfm.REF.selcen.2004.1363">Selcen &#x00026; Engel 2004</xref>]</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">LDB3</italic> (known previously <italic toggle="yes">as ZASP</italic>), encoding LIM domain-binding protein 3 [<xref ref-type="bibr" rid="mfm.REF.selcen.2005.269">Selcen &#x00026; Engel 2005</xref>]</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">FLNC</italic>, encoding filamin-C [<xref ref-type="bibr" rid="mfm.REF.vorgerd.2005.297">Vorgerd et al 2005</xref>]</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">BAG3</italic>, encoding BAG family molecular chaperone regulator 3 (Bag3) [<xref ref-type="bibr" rid="mfm.REF.selcen.2009.83">Selcen et al 2009</xref>]</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">FHL1</italic>, encoding four and a half LIM containing protein 1 [<xref ref-type="bibr" rid="mfm.REF.selcen.2011.1951">Selcen et al 2011</xref>]</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">DNAJB6</italic>, encoding DnaJ homolog subfamily B member 6 (heat shock protein 40) [<xref ref-type="bibr" rid="mfm.REF.harms.2012.407">Harms et al 2012</xref>; <xref ref-type="bibr" rid="mfm.REF.sarparanta.2012.450">Sarparanta et al 2012</xref>; Author, personal observation]</p>
            </list-item>
          </list>
          <p>
            <bold>Clinical testing</bold>
          </p>
          <table-wrap id="mfm.T.summary_of_molecular_genetic_testi" position="anchor" orientation="portrait">
            <label>Table 1.</label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Myofibrillar Myopathy</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_2" align="left" valign="top" rowspan="1" colspan="1">Proportion of MFM Attributed to Mutations in This Gene&#x000a0;<sup>2</sup></th>
                  <th id="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Mutations Detected&#x000a0;<sup>3</sup></th>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                    <italic toggle="yes">DES</italic>
                  </td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_2" align="left" valign="middle" rowspan="2" colspan="1">7%</td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown, none reported&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                    <italic toggle="yes">CRYAB</italic>
                  </td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_2" align="left" valign="middle" rowspan="2" colspan="1">3%</td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants</td>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown; none reported&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                    <italic toggle="yes">MYOT</italic>
                  </td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_2" align="left" valign="middle" rowspan="2" colspan="1">9%</td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants</td>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown, none reported&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_1" align="left" valign="middle" rowspan="3" colspan="1">
                    <italic toggle="yes">LDB3</italic>
                  </td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_2" align="left" valign="middle" rowspan="3" colspan="1">11%</td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants</td>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis of select exons</td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants in exon 6&#x000a0;<sup>8</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown, none reported&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                    <italic toggle="yes">FLNC</italic>
                  </td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_2" align="left" valign="middle" rowspan="2" colspan="1">3%</td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants</td>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown, none reported&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                    <italic toggle="yes">BAG3</italic>
                  </td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_2" align="left" valign="middle" rowspan="2" colspan="1">5%</td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants</td>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown, none reported&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">
                    <italic toggle="yes">FHL1</italic>
                  </td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">3%</td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants</td>
                </tr>
                <tr>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">
                    <italic toggle="yes">DNAJB6</italic>
                  </td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">2%</td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_b_mfm.T.summary_of_molecular_genetic_testi_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="mfm.TF.2">
                <label>1.</label>
                <p>See <related-object source-id="gene" document-id="mfm" object-id="mfm.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="mfm.TF.2.1">
                <label>2.</label>
                <p>Frequencies based on Mayo Clinic MFM cohort</p>
              </fn>
              <fn id="mfm.TF.2.2">
                <label>3.</label>
                <p>See <xref ref-type="sec" rid="mfm.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="mfm.TF.2.3">
                <label>4.</label>
                <p>Examples of mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="mfm.TF.2.4">
                <label>5.</label>
                <p>Expected to identify approximately 99% of mutations in the coding region.</p>
              </fn>
              <fn id="mfm.TF.2.5">
                <label>6.</label>
                <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="mfm.TF.2.6">
                <label>7.</label>
                <p>No large deletions or duplications of <italic toggle="yes">DES</italic>, <italic toggle="yes">MYOT</italic>, <italic toggle="yes">LDB3</italic>, CRYAB, <italic toggle="yes">FLNC</italic>, or <italic toggle="yes">BAG3</italic> have been reported to cause myofibrillar myopathy. </p>
              </fn>
              <fn id="mfm.TF.2.7">
                <label>8.</label>
                <p>Exons sequenced may vary among laboratories.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="mfm.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Generic diagnosis of an MFM can be made on clinical and histologic grounds.</p>
            </list-item>
            <list-item>
              <p>The diagnosis of a specific MFM is based on molecular genetic testing:</p>
              <list list-type="bullet">
                <list-item>
                  <p>If the proband&#x02019;s symptoms suggest a candidate gene (see <xref ref-type="sec" rid="mfm.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>), perform sequence analysis of that gene first.</p>
                </list-item>
                <list-item>
                  <p>If no mutation is identified, perform sequence analysis for the remaining genes (<xref ref-type="table" rid="mfm.T.summary_of_molecular_genetic_testi">Table 1</xref>).</p>
                </list-item>
                <list-item>
                  <p>At present no clear criteria for testing for deletions/duplications exist.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Predictive testing</bold> for at-risk asymptomatic adult family members requires prior identification of the disease-causing mutation in the family.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the disease-causing mutation in the family.</p>
        </sec>
      </sec>
      <sec id="mfm.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="mfm.Natural_History">
          <title>Clinical Description</title>
          <p>In the Mayo Clinic series of 80 individuals with myofibrillar myopathy (MFM), the age of onset varied from two to 77 years. The age at diagnosis ranged from 11 to 82 years. <italic toggle="yes">BAG3</italic>-related myofibrillar myopathy (Bag3opathy) characteristically presents in the first or second decade of life and is typically fatal. Desminopathies may also present in the first decade of life, usually with cardiomyopathy. However, the majority of MFM presents after age 40 years.</p>
          <p>The predominant presenting symptom in MFM is slowly progressive weakness; a minority of individuals experience sensory symptoms, muscle stiffness, aching, or cramps. The weakness can involve both proximal and distal muscles; however, distal muscle weakness is 25% more common than proximal weakness.</p>
          <p>Objective clinical signs or EMG findings of peripheral neuropathy are present in approximately 20% of affected individuals, but muscle biopsy studies suggest an even higher frequency of peripheral nerve involvement.</p>
          <p>Overt cardiomyopathy can be a presenting manifestation or can appear during the evolution of myofibrillar myopathy in 15%-30% of affected individuals.</p>
          <p>A restrictive ventilatory defect can result from respiratory muscle weakness.</p>
          <p>Variable expressivity has been observed in kinships with mutations in <italic toggle="yes">DES</italic>, with some family members showing signs of cardiomyopathy only, some showing signs of both myopathy and cardiomyopathy, and some with reduced penetrance who have signs of neither myopathy nor cardiomyopathy. </p>
        </sec>
        <sec id="mfm.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No morphologic features consistently or reliably predict mutation in a given gene.</p>
          <p>The only genotype-phenotype correlations detected to date are:</p>
          <list list-type="bullet">
            <list-item>
              <p>Cataracts were present in affected members of one of the three reported kinships with mutations in <italic toggle="yes">CRYAB</italic>, the gene encoding alpha crystallin B chain (also known as &#x003b1;-B crystallin) [<xref ref-type="bibr" rid="mfm.REF.vicart.1998.92">Vicart et al 1998</xref>].</p>
            </list-item>
            <list-item>
              <p>Neuropathy and cardiomyopathy were observed in families with mutations in <italic toggle="yes">MYOT</italic> [<xref ref-type="bibr" rid="mfm.REF.selcen.2004.1363">Selcen &#x00026; Engel 2004</xref>] and <italic toggle="yes">BAG3</italic> [<xref ref-type="bibr" rid="mfm.REF.selcen.2009.83">Selcen et al 2009</xref>].</p>
            </list-item>
            <list-item>
              <p>Rigid spine has been observed in Bag3opathy [<xref ref-type="bibr" rid="mfm.REF.selcen.2009.83">Selcen et al 2009</xref>] and <italic toggle="yes">FHL1-</italic>related MFM [<xref ref-type="bibr" rid="mfm.REF.selcen.2011.1951">Selcen et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>Neuropathy and cardiomyopathy also occur in individuals in whom the genetic basis of myofibrillar myopathy has not been established.</p>
            </list-item>
          </list>
        </sec>
        <sec id="mfm.Penetrance">
          <title>Penetrance</title>
          <p>Data are insufficient to draw conclusions about penetrance.</p>
        </sec>
        <sec id="mfm.Anticipation">
          <title>Anticipation</title>
          <p>No convincing evidence of anticipation has been documented.</p>
        </sec>
        <sec id="mfm.Nomenclature">
          <title>Nomenclature</title>
          <p>"&#x02026; The light microscopic features of myofibrillar myopathy were described in the 1970s and 1980s under such names as 'myopathy with inclusion bodies' [<xref ref-type="bibr" rid="mfm.REF.nakashima.1970.270">Nakashima et al 1970</xref>], 'atypical myopathy with myofibrillar aggregates' [<xref ref-type="bibr" rid="mfm.REF.kinoshita.1975.417">Kinoshita et al 1975</xref>], 'autosomal dominant cardiomyopathy with inclusions' [<xref ref-type="bibr" rid="mfm.REF.clark.1978.399">Clark et al 1978</xref>], 'cardioskeletal myopathy with intrasarcoplasmic dense granulofilamentous material' [<xref ref-type="bibr" rid="mfm.REF.fardeau.1978.411">Fardeau et al 1978</xref>], 'autosomal dominant spheroid body myopathy' [<xref ref-type="bibr" rid="mfm.REF.goebel.1978.14">Goebel et al 1978</xref>], &#x02018;myopathy with sarcoplasmic bodies and desmin filaments&#x02019; [<xref ref-type="bibr" rid="mfm.REF.edstrom.1980.171">Edstr&#x000f6;m et al 1980</xref>], 'congenital myopathy with cytoplasmic bodies' [<xref ref-type="bibr" rid="mfm.REF.wolburg.1982.55">Wolburg et al 1982</xref>], 'congenital myopathy with Mallory body-like inclusions' [<xref ref-type="bibr" rid="mfm.REF.fidzianska.1983.195">Fidzianska et al 1983</xref>], and 'familial cardiomyopathy with subsarcolemmal vermiform deposits' [<xref ref-type="bibr" rid="mfm.REF.calderon.1987.108">Calderon et al 1987</xref>]. Later, however, it became apparent that some authors described the same pathologic reaction under different names; that more than one pathologic alteration thought to be specific for a single disorder could be present in the same muscle specimen, or even in the same muscle fiber; and that in each instance the pathologic changes involve the Z-disks of the myofibril. <xref ref-type="bibr" rid="mfm.REF.edstrom.1980.171">Edstr&#x000f6;m et al [1980]</xref> noted that some inclusions or material around them reacted for desmin. This generated the names of 'desmin storage myopathy' [<xref ref-type="bibr" rid="mfm.REF.horowitz.1994.151">Horowitz &#x00026; Schmalbruch 1994</xref>] and later 'desmin-related myopathies' [<xref ref-type="bibr" rid="mfm.REF.goebel.1997.426">Goebel 1997</xref>]. In 1996 and 1997, detailed immunocytochemical studies revealed that many proteins, not just desmin, accumulate in the abnormal fibers, and prompted the use of the noncommittal term myofibrillar myopathy [<xref ref-type="bibr" rid="mfm.REF.debleecker.1996.563">De Bleecker et al 1996</xref>, <xref ref-type="bibr" rid="mfm.REF.nakano.1997.850">Nakano et al 1997</xref>]&#x02026;"</p>
          <p>[<xref ref-type="bibr" rid="mfm.REF.selcen.2004.439">Selcen et al 2004</xref>; republished with permission of Oxford University Press]</p>
          <p>Myofibrillar myopathy has also been referred to as desmin storage myopathy, desmin-related myopathy, or protein surplus myopathy. Because myofibrillar myopathy is genetically heterogeneous and the disease-causing protein or involved gene is known only in a minority of cases, because multiple other proteins besides desmin are also overexpressed in muscle, and because myotilin is not related to desmin, the generic term "myofibrillar myopathy" is the preferred designation until the gene(s) in which mutations occur are determined. When the disease-associated gene or protein is identified, designations such as desminopathy, &#x003b1;-B crystallinopathy, myotilinopathy, zaspopathy (Markesbery-Griggs late-onset distal myopathy), filaminopathy, or <italic toggle="yes">BAG3</italic>-related myofibrillar myopathy are appropriate.</p>
        </sec>
        <sec id="mfm.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of myofibrillar myopathy cannot be estimated at this time. </p>
        </sec>
      </sec>
      <sec id="mfm.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Cardiomyopathy can occur with each genetically defined type of MFM.</p>
        <p>Mutation of <italic toggle="yes">CRYAB</italic> can also cause cataracts without causing myofibrillar myopathy.</p>
        <p>Mutation of <italic toggle="yes">MYOT</italic> can also cause a limb girdle-like phenotype that has been designated as LGMD1A [<xref ref-type="bibr" rid="mfm.REF.hauser.2000.2141">Hauser et al 2000</xref>] and also as a distal myopathy [<xref ref-type="bibr" rid="mfm.REF.fischer.2006.361">Fischer et al 2006</xref>, <xref ref-type="bibr" rid="mfm.REF.penissonbesnier.2006.427">Penisson-Besnier et al 2006</xref>] (see <related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter">Limb-Girdle Muscular Dystrophy Overview</related-object>).</p>
        <p>Mutation of <italic toggle="yes">FHL1</italic> is associated with several phenotypes: X-linked childhood-onset reducing body myopathy; X-linked early-onset severe reducing body myopathy; <italic toggle="yes">FHL1</italic>-related X-linked <related-object link-type="booklink" source-id="gene" document-id="edmd" document-type="chapter">Emery-Dreifuss muscular dystrophy</related-object>; X-linked myopathy with postural muscle atrophy; X-linked dominant scapuloperoneal myopathy. </p>
        <p>Mutation of <italic toggle="yes">DBAJB6</italic> is associated with limb-girdle muscular dystrophy type 1E. </p>
      </sec>
      <sec id="mfm.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The principle differential diagnoses are late-onset myopathies and especially myopathies with a predominantly distal distribution:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="myotonic-d" document-type="chapter"><bold>Myotonic dystrophy type 1</bold></related-object>
<bold>(DM1)</bold> is a multisystem disorder that affects skeletal and smooth muscle as well as the eye, heart, endocrine system, and central nervous system. The clinical findings, which span a continuum from mild to severe, have been categorized into three somewhat overlapping phenotypes: mild, classic, and congenital. Mild DM1 is characterized by cataract and mild myotonia (sustained muscle contraction); life span is normal. Classic DM1 is characterized by muscle weakness and wasting, myotonia, cataract, and often by cardiac conduction abnormalities. Congenital DM1 is characterized by hypotonia and severe generalized weakness at birth, often with respiratory insufficiency and early death; intellectual disability is common. DM1 is caused by expansion of a CTG trinucleotide repeat in <italic toggle="yes">DMPK</italic>. Molecular genetic testing detects mutations in nearly 100% of affected individuals. DM1 is inherited in an autosomal dominant manner.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="myotonic-d2" document-type="chapter"><bold>Myotonic dystrophy type 2</bold></related-object>
<bold>(DM2),</bold> also known as proximal myotonic myopathy (PROMM), is characterized by myotonia and muscle dysfunction (weakness, pain, and stiffness), and less commonly by cardiac conduction defects, iridescent posterior subcapsular cataracts, insulin-insensitive type 2 diabetes mellitus, and testicular failure. Although myotonia has been reported during the first decade, onset is typically in the third decade, most commonly with fluctuating or episodic muscle pain that can be debilitating and weakness of the neck flexors and finger flexors. Subsequently, weakness occurs in the elbow extensors and the hip flexors and extensors. Facial weakness and weakness of the ankle dorsiflexors are less common. Myotonia rarely causes severe symptoms. <italic toggle="yes">CNBP</italic> (<italic toggle="yes">ZNF9</italic>), the only gene known to be associated with DM2, has in intron 1 a complex repeat motif, (TG)n(TCTG)n(CCTG)n, expansion of which causes DM2. The number of CCTG repeats in expanded alleles ranges from approximately 75 to more than 11,000 (mean: ~5,000 repeats). The detection frequency of a <italic toggle="yes">CNBP</italic> CCTG expansion is more than 99%. DM2 is inherited in an autosomal dominant manner.</p>
          </list-item>
          <list-item>
            <p>
              <bold>Motor and sensory neuropathies</bold>
            </p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ibm" document-type="chapter"><bold>Inclusion body myopathy type 2</bold></related-object>
<bold>(IBM2)</bold> is characterized by adult-onset, slowly progressive distal muscle weakness that begins with gait disturbance and foot drop secondary to anterior tibialis muscle weakness. Weakness eventually includes the hand and thigh muscles, but commonly spares the quadriceps muscles, even in advanced disease. Affected individuals are usually wheelchair bound about 20 years after onset. Muscle histopathology typically shows rimmed vacuoles and characteristic filamentous inclusions. <italic toggle="yes">GNE</italic>, which encodes the bifunctional enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, is the only gene known to be associated with IBM2. IBM2 is inherited in an autosomal recessive manner.</p>
          </list-item>
          <list-item>
            <p><bold>Inclusion body myositis,</bold> a slowly progressive and typically sporadic vacuolar myopathy, is associated with an autoaggressive inflammatory exudate and small congophilic inclusions.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="miyoshi" document-type="chapter"><bold>Dysferlinopathy</bold></related-object><bold>,</bold> caused by mutations in <italic toggle="yes">DYSF</italic>, includes a spectrum of muscle disease characterized mainly by two phenotypes: Miyoshi myopathy, with primarily distal weakness; and limb-girdle muscular dystrophy type 2B (LGMD2B), with primarily proximal weakness. Miyoshi myopathy is characterized in young adults by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Dysferlinopathy is inherited in an autosomal recessive manner.</p>
          </list-item>
          <list-item>
            <p><bold>Other muscular dystrophies</bold> that can predominantly affect distal muscles include <related-object link-type="booklink" source-id="gene" document-id="udd" document-type="chapter">tibial muscular dystrophy</related-object> (Udd distal myopathy), telethoninopathy, <related-object link-type="booklink" source-id="gene" document-id="mpd1" document-type="chapter">Laing distal myopathy</related-object> caused by <italic toggle="yes">MYH7</italic> mutation, Welander's distal dystrophy, <related-object link-type="booklink" source-id="gene" document-id="fsh" document-type="chapter">facioscapulohumeral dystrophy</related-object>, anoctamin-5 related muscular dystrophy, and other sporadically occurring or dominantly inherited muscular dystrophies.</p>
          </list-item>
        </list>
      </sec>
      <sec id="mfm.Management">
        <title>Management</title>
        <sec id="mfm.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with myofibrillar myopathy (MFM), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>EMG</p>
            </list-item>
            <list-item>
              <p>Routine ECG to identify arrhythmias and cardiac conduction defects; Holter monitoring if symptoms suggest an intermittent arrhythmia; echocardiogram if cardiac symptoms are present</p>
            </list-item>
            <list-item>
              <p>Respiratory function tests if respiratory symptoms are present</p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="mfm.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Pacemaker and implantable cardioverter defibrillator (ICD) should be considered in individuals with arrhythmia and/or cardiac conduction defects. Individuals with progressive or life-threatening cardiomyopathy are candidates for cardiac transplantation.</p>
          <p>Respiratory support, consisting of continuous or bilevel positive airway pressure (CPAP or BIPAP), initially at night and later in the daytime, is indicated in individuals with hypercapnea and other signs of incipient ventilatory failure.</p>
          <p>Range of motion physical therapy and assistive devices are appropriate for those with advanced muscle weakness. Treatment of scoliosis by spinal fusion is appropriate. Orthoses are indicated for treatment of foot drop.</p>
        </sec>
        <sec id="mfm.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Pacemaker or implantable cardioverter defibrillator placement for individuals with arrhythmogenic cardiomyopathy.</p>
        </sec>
        <sec id="mfm.Surveillance">
          <title>Surveillance</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Physical examination to monitor disease progression yearly or less often depending on rate of progression</p>
            </list-item>
            <list-item>
              <p>Electrocardiogram and/or echocardiogram yearly for early detection of cardiomyopathy </p>
            </list-item>
            <list-item>
              <p>Pulmonary function tests for individuals with exertional or nocturnal dyspnea.</p>
            </list-item>
          </list>
        </sec>
        <sec id="mfm.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="mfm.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="mfm.Pregnancy_Management">
          <title>Pregnancy Management </title>
          <p>Affected pregnant women may need assistance during delivery if they have significant weakness of their abdominal muscles. </p>
        </sec>
        <sec id="mfm.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="mfm.Other">
          <title>Other</title>
          <p>The role of strengthening exercises has not been defined.</p>
        </sec>
      </sec>
      <sec id="mfm.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="mfm.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Myofibrillar myopathy (MFM) is most commonly inherited in an autosomal dominant manner. Exceptions include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Autosomal recessive inheritance of <italic toggle="yes">CRYAB</italic> frameshift mutations that predict premature termination of the protein (see <xref ref-type="sec" rid="mfm.Molecular_Genetics">Molecular Genetics</xref>).</p>
            </list-item>
            <list-item>
              <p>X-linked inheritance of <italic toggle="yes">FHL1</italic> mutations </p>
            </list-item>
          </list>
        </sec>
        <sec id="mfm.Risk_to_Family_Members__Autosomal_Do">
          <title>Risk to Family Members &#x02014; Autosomal Dominant Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Approximately 25% of individuals diagnosed with autosomal dominant (AD) myofibrillar myopathy have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with AD myofibrillar myopathy may have the disorder as the result of a <italic toggle="yes">de novo</italic> gene mutation. The proportion of cases caused by <italic toggle="yes">de novo</italic> mutations is unknown.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> mutation include clinical examination looking for weakness, EMG, and possible muscle biopsy. Molecular genetic testing may also be appropriate if a disease-causing mutation has been identified in the proband.</p>
            </list-item>
          </list>
          <p>Note: Twenty-five percent of individuals diagnosed with myofibrillar myopathy have an affected parent; in other individuals, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband cannot be determined with confidence.</p>
            </list-item>
            <list-item>
              <p>Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with AD myofibrillar myopathy has a 50% chance of inheriting the mutation.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents. If a parent is affected or has a disease-causing mutation, his or her family members are at risk.</p>
        </sec>
        <sec id="mfm.Risk_to_Family_Members__Autosomal_Re">
          <title>Risk to Family Members &#x02014; Autosomal Recessive Inheritance</title>
          <p><bold>Parents of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes (i.e., carriers of one mutant allele).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. </p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3. </p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Unless an individual with MFM has children with an affected individual or a carrier of a <italic toggle="yes">CRYAB</italic> mutation, his/her offspring will be obligate heterozygotes (carriers) for a disease-causing frameshift mutation in <italic toggle="yes">CRYAB</italic>. </p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier. </p>
        </sec>
        <sec id="mfm.Carrier_Detection_1">
          <title>Carrier Detection </title>
          <p>Carrier testing for at-risk family members is possible if the <italic toggle="yes">CRYAB</italic> disease-causing mutations in the family have been identified. </p>
        </sec>
        <sec id="mfm.Risk_to_Family_Members__XLinked_Inhe">
          <title>Risk to Family Members &#x02014; X-Linked Inheritance</title>
          <p><bold>Parents of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The father of an affected male will not have MFM nor will he be a carrier of the <italic toggle="yes">FHL1</italic> mutation.</p>
            </list-item>
            <list-item>
              <p>In a family with more than one affected individual, the mother of an affected male is an obligate carrier. Note: If a woman has more than one affected child and no other affected relatives and if the disease-causing mutation cannot be detected in her leukocyte DNA, she has germline mosaicism. </p>
            </list-item>
            <list-item>
              <p>If a male is the only affected family member (i.e., a simplex case), the mother may be a carrier or the affected male may have a <italic toggle="yes">de novo</italic> mutation and, thus, the mother is not a carrier. The percent of simplex cases representing <italic toggle="yes">de novo</italic> mutations is not known. </p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs depends on the carrier status of the mother. </p>
            </list-item>
            <list-item>
              <p>If the mother of the proband has a <italic toggle="yes">FHL1</italic> mutation, the chance of transmitting it in each pregnancy is 50%. Males who inherit the mutation will be affected; females who inherit the mutation will be carriers and may be severely affected.</p>
            </list-item>
            <list-item>
              <p>If the proband represents a simplex case (i.e., a single occurrence in a family) and if the disease-causing mutation cannot be detected in the leukocyte DNA of the mother, the risk to sibs is low but greater than that of the general population because of the possibility of maternal germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a male proband.</bold> Affected males pass the <italic toggle="yes">FHL1</italic> mutation to all of their daughters and none of their sons. </p>
          <p><bold>Other family members.</bold> The proband's maternal aunts may be at risk of being carriers and the aunts&#x02019; offspring, depending on their gender, may be at risk of being carriers or of being affected.</p>
          <p>Note: Molecular genetic testing may be able to identify the family member in whom a <italic toggle="yes">de novo</italic> mutation arose, information that could help determine genetic risk status of the extended family.</p>
        </sec>
        <sec id="mfm.Carrier_Detection_2">
          <title>Carrier Detection </title>
          <p>Carrier testing for at-risk female relatives is possible if the <italic toggle="yes">FHL1</italic> mutation in the family has been identified. </p>
        </sec>
        <sec id="mfm.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> mutation.</bold> When neither parent of a proband with an autosomal dominant condition has clinical evidence of the disorder and/or the disease-causing mutation, the proband likely has a <italic toggle="yes">de novo</italic> mutation. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p><bold>Family planning</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling&#x000a0;(including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being affected or carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals. </p>
        </sec>
        <sec id="mfm.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the disease-causing mutation(s) have been identified in the family, prenatal diagnosis for pregnancies at increased risk is possible by analysis of DNA extracted from fetal cells obtained by amniocentesis (usually performed at ~15-18 weeks&#x02019; gestation) or chorionic villus sampling (usually performed at ~10-12 weeks&#x02019; gestation). Such testing may be available through laboratories that offer either testing for the gene of interest or custom testing.</p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the disease-causing mutation(s) have been identified. </p>
        </sec>
      </sec>
      <sec id="mfm.Resources">
        <title>Resources</title>
      </sec>
      <sec id="mfm.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="mfm.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Because myofibrillar myopathy is caused by mutation in any of eight different genes and each disease-associated gene may have different types of mutations, the molecular pathogenesis may vary from case to case. However, in all myofibrillar myopathies, the initial pathologic change involves disintegration of the Z-disk, and all disease proteins identified to date are involved in maintaining the structural integrity of the Z-disk. Because the Z-disks are sites of tension transmission between sarcomeres, the myofibrils fall apart when the Z-disks disintegrate.</p>
          <p><bold>Animal models.</bold> Desmin knockout mice show normal development of cardiac and skeletal muscle but subsequently show myofiber necrosis and phagocytosis [<xref ref-type="bibr" rid="mfm.REF.capetanaki.1997.103">Capetanaki et al 1997</xref>]. This model is not comparable with human cases of desminopathy in which missense mutations weaken sarcomere structure and are associated with abnormal accumulation of desmin and other proteins. Transgenic mice that produce an inactivated form of human desmin (p.Arg173_Glu179del) show desmin immunoreactive aggregates in myocardium [<xref ref-type="bibr" rid="mfm.REF.munozmarmol.1998.11312">Munoz-Marmol et al 1998</xref>]. Transgenic mice expressing an &#x003b1;-B crystallin mutant protein (p.Arg120Gly) develop a severe cardiomyopathy with abnormal accumulation of desmin and &#x003b1;-B crystallin in the heart; muscle pathology was not mentioned in this report [<xref ref-type="bibr" rid="mfm.REF.wang.2001.84">Wang et al 2001</xref>].</p>
          <sec id="mfm.DES">
            <title><italic toggle="yes">DES</italic>
</title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">DES</italic> consists of nine exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mfm" object-id="mfm.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> More than forty mutations including missense, frameshifting nucleotide insertion, small in-frame deletion, and splice-site mutations have been reported [<xref ref-type="bibr" rid="mfm.REF.goldfarb.2004.723">Goldfarb et al 2004</xref>]. See <xref ref-type="table" rid="mfm.T.selected_des_pathogenic_variants">Table 2</xref>.</p>
            <table-wrap id="mfm.T.selected_des_pathogenic_variants" position="anchor" orientation="portrait">
              <label>Table 2.</label>
              <caption>
                <p>Selected <italic toggle="yes">DES</italic> Pathogenic Variants</p>
              </caption>
              <table>
                <tbody>
                  <tr>
                    <th id="hd_b_mfm.T.selected_des_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_b_mfm.T.selected_des_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                    <th id="hd_b_mfm.T.selected_des_pathogenic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                  <tr>
                    <td headers="hd_b_mfm.T.selected_des_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.517_537del</td>
                    <td headers="hd_b_mfm.T.selected_des_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Arg173_Glu179del</td>
                    <td headers="hd_b_mfm.T.selected_des_pathogenic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/55749931">NM_001927.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/55749932">NP_001918.3</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="mfm.TF.3">
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
                </fn>
                <fn id="mfm.TF.3.1">
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> Desmin, comprising 470 amino acids, is a constituent of intermediate filaments in cardiac and skeletal muscle linking Z-disks with each other and to the subsarcolemmal cytoskeleton.</p>
            <p><bold>Abnormal gene product.</bold> Expression data suggest abnormal aggregation of mutant desmin molecules in heterologous systems. Mutations may interfere with desmin assembly and filament formation [<xref ref-type="bibr" rid="mfm.REF.bar.2006.1031">B&#x000e4;r et al 2006</xref>].</p>
          </sec>
          <sec id="mfm.CRYAB">
            <title>
              <italic toggle="yes">CRYAB</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">CRYAB</italic> consists of three exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mfm" object-id="mfm.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> A nonsense mutation, a missense mutation, and a small frameshifting deletion have been reported [<xref ref-type="bibr" rid="mfm.REF.vicart.1998.92">Vicart et al 1998</xref>, <xref ref-type="bibr" rid="mfm.REF.selcen.2003.804">Selcen &#x00026; Engel 2003</xref>]. Recently, autosomal recessive inheritance was shown for the p.Ser115ProfsTer14 [<xref ref-type="bibr" rid="mfm.REF.forrest.2011.37">Forrest et al 2011</xref>] and Ser21AlafsTer24 [<xref ref-type="bibr" rid="mfm.REF.delbigio.2011.866">Del Bigio et al 2011</xref>] frameshift mutations. See <xref ref-type="table" rid="mfm.T.selected_cryab_pathogenic_variants">Table 3</xref>.</p>
            <table-wrap id="mfm.T.selected_cryab_pathogenic_variants" position="anchor" orientation="portrait">
              <label>Table 3.</label>
              <caption>
                <p>Selected <italic toggle="yes">CRYAB</italic> Pathogenic Variants </p>
              </caption>
              <table>
                <tbody>
                  <tr>
                    <th id="hd_b_mfm.T.selected_cryab_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_b_mfm.T.selected_cryab_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                    <th id="hd_b_mfm.T.selected_cryab_pathogenic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                  <tr>
                    <td headers="hd_b_mfm.T.selected_cryab_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.60delC&#x000a0;<sup>1</sup></td>
                    <td headers="hd_b_mfm.T.selected_cryab_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Ser21AlafsTer24</td>
                    <td headers="hd_b_mfm.T.selected_cryab_pathogenic_variants_1_1_1_3" align="left" valign="middle" rowspan="3" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/4503056">NM_001885.1</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/4503057">NP_001876.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_b_mfm.T.selected_cryab_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.343delT&#x000a0;<sup>2</sup></td>
                    <td headers="hd_b_mfm.T.selected_cryab_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Ser115ProfsTer14</td>
                  </tr>
                  <tr>
                    <td headers="hd_b_mfm.T.selected_cryab_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.358A&#x0003e;G</td>
                    <td headers="hd_b_mfm.T.selected_cryab_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Arg120Gly</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="mfm.TF.4">
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
                </fn>
                <fn id="mfm.TF.4.1">
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="mfm.TF.4.2">
                  <p>1. <xref ref-type="bibr" rid="mfm.REF.delbigio.2011.866">Del Bigio et al [2011]</xref></p>
                </fn>
                <fn id="mfm.TF.4.3">
                  <p>2. Homozygosity in an affected individual for this mutation in an autosomal recessive form of MFM [<xref ref-type="bibr" rid="mfm.REF.forrest.2011.37">Forrest et al 2011</xref>]</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> Alpha crystallin B chain (&#x003b1;-B crystallin) is a small heat-shock chaperone protein required for maintaining the structural integrity of desmin. It is composed of 175 amino acid residues.</p>
            <p><bold>Abnormal gene product.</bold> Mutant alpha crystallin B chain molecules form smaller molecular-weight polymers than wild type in human muscle. In heterologous cells that constitutively express desmin, misfolded desmin molecules appear in aggregates.</p>
          </sec>
          <sec id="mfm.MYOT_TTID">
            <title><italic toggle="yes">MYOT</italic> (<italic toggle="yes">TTID</italic>)</title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">MYOT</italic> consists of ten exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mfm" object-id="mfm.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> Five missense mutations have been reported; all are in exon 2 [<xref ref-type="bibr" rid="mfm.REF.hauser.2000.2141">Hauser et al 2000</xref>, <xref ref-type="bibr" rid="mfm.REF.hauser.2002.1428">Hauser et al 2002</xref>, <xref ref-type="bibr" rid="mfm.REF.selcen.2004.1363">Selcen &#x00026; Engel 2004</xref>]. See <xref ref-type="table" rid="mfm.T.selected_myot_pathogenic_variants">Table 4</xref>.</p>
            <table-wrap id="mfm.T.selected_myot_pathogenic_variants" position="anchor" orientation="portrait">
              <label>Table 4.</label>
              <caption>
                <p>Selected <italic toggle="yes">MYOT</italic> Pathogenic Variants</p>
              </caption>
              <table>
                <tbody>
                  <tr>
                    <th id="hd_b_mfm.T.selected_myot_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_b_mfm.T.selected_myot_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                    <th id="hd_b_mfm.T.selected_myot_pathogenic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                  <tr>
                    <td headers="hd_b_mfm.T.selected_myot_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.170C&#x0003e;T</td>
                    <td headers="hd_b_mfm.T.selected_myot_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Thr57Ile</td>
                    <td headers="hd_b_mfm.T.selected_myot_pathogenic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/209693442">NM_006790.2</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/5803106">NP_006781.1</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="mfm.TF.5">
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
                </fn>
                <fn id="mfm.TF.5.1">
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> Myotilin is a key Z-disk protein that interacts with &#x003b1;-actinin, filamin-C, and actin. It has 498 amino acid residues.</p>
            <p><bold>Abnormal gene product.</bold> Mutant myotilin is predicted to weaken the linkage of Z-disk filaments to thin filaments. Transgenic mice with the p.Thr57Ile mutation and muscle disease similar to LGMD1A have been described [<xref ref-type="bibr" rid="mfm.REF.garvey.2006.2348">Garvey et al 2006</xref>].</p>
          </sec>
          <sec id="mfm.LDB3_ZASP">
            <title><italic toggle="yes">LDB3</italic> (<italic toggle="yes">ZASP</italic>)</title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">LDB3</italic> consists of 16 exons. It is alternatively spliced. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mfm" object-id="mfm.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> Three missense mutations have been reported [<xref ref-type="bibr" rid="mfm.REF.selcen.2005.269">Selcen &#x00026; Engel 2005</xref>]. See <xref ref-type="table" rid="mfm.T.selected_ldb3_pathogenic_variants">Table 5</xref>.</p>
            <table-wrap id="mfm.T.selected_ldb3_pathogenic_variants" position="anchor" orientation="portrait">
              <label>Table 5.</label>
              <caption>
                <p>Selected <italic toggle="yes">LDB3</italic> Pathogenic Variants</p>
              </caption>
              <table>
                <tbody>
                  <tr>
                    <th id="hd_b_mfm.T.selected_ldb3_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_b_mfm.T.selected_ldb3_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                    <th id="hd_b_mfm.T.selected_ldb3_pathogenic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                  <tr>
                    <td headers="hd_b_mfm.T.selected_ldb3_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.440C&#x0003e;T&#x000a0;<sup>1</sup></td>
                    <td headers="hd_b_mfm.T.selected_ldb3_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Ala147Val</td>
                    <td headers="hd_b_mfm.T.selected_ldb3_pathogenic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/122056618">NM_001080116.1</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001073585.1">NP_001073585.1</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="mfm.TF.6">
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
                </fn>
                <fn id="mfm.TF.6.1">
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="mfm.TF.6.2">
                  <p>1. Presents as a distal myopathy (see <xref ref-type="sec" rid="mfm.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>)</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> LIM domain-binding protein 3 (Zasp) is a key Z-disk protein that interacts with &#x003b1;-actinin and protein kinase C. It has 283 amino acid residues.</p>
            <p><bold>Abnormal gene product.</bold> Mutant LIM domain-binding protein 3 (Zasp) is predicted to weaken the linkage of Z-disk filaments to thin filaments.</p>
          </sec>
          <sec id="mfm.FLNC">
            <title>
              <italic toggle="yes">FLNC</italic>
            </title>
            <p><bold>Gene structure.</bold> Two <italic toggle="yes">FLNC</italic> transcript variants encoding different isoforms have been found for this gene (see <related-object source-id="gene" document-id="mfm" object-id="mfm.molgen.TA">Table A</related-object>, <bold>Gene</bold>). The longer isoform, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001458.4">NM_001458.4</ext-link>, consists of 48 exons.</p>
            <p><bold>Pathogenic allelic variants.</bold> One nonsense mutation and in-frame deletions have been reported [<xref ref-type="bibr" rid="mfm.REF.vorgerd.2005.297">Vorgerd et al 2005</xref>, <xref ref-type="bibr" rid="mfm.REF.shatunov.2009.656">Shatunov et al 2009</xref>, <xref ref-type="bibr" rid="mfm.REF.luan.2010.390">Luan et al 2010</xref>].</p>
            <p><bold>Normal gene product.</bold> Filamin-C is a Z-disk protein that interacts with actin and myotilin. The protein <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001449.3">NP_001449.3</ext-link> has 2725 amino acid residues.</p>
            <p><bold>Abnormal gene product.</bold> Mutant filamin-C has a disturbed secondary structure that prevents normal dimerization.</p>
          </sec>
          <sec id="mfm.BAG3">
            <title>
              <italic toggle="yes">BAG3</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">BAG3</italic> consists of four exons. No splice variants have been identified. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mfm" object-id="mfm.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> The mutation p.Pro209Leu has been reported [<xref ref-type="bibr" rid="mfm.REF.selcen.2009.83">Selcen et al 2009</xref>]. See <xref ref-type="table" rid="mfm.T.selected_bag3_pathogenic_variants">Table 6</xref>.</p>
            <table-wrap id="mfm.T.selected_bag3_pathogenic_variants" position="anchor" orientation="portrait">
              <label>Table 6.</label>
              <caption>
                <p>Selected <italic toggle="yes">BAG3</italic> Pathogenic Variants</p>
              </caption>
              <table>
                <tbody>
                  <tr>
                    <th id="hd_b_mfm.T.selected_bag3_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_b_mfm.T.selected_bag3_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                    <th id="hd_b_mfm.T.selected_bag3_pathogenic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                  <tr>
                    <td headers="hd_b_mfm.T.selected_bag3_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.626C&#x0003e;T</td>
                    <td headers="hd_b_mfm.T.selected_bag3_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Pro209Leu</td>
                    <td headers="hd_b_mfm.T.selected_bag3_pathogenic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/62530382">NM_004281.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/14043024">NP_004272.2</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="mfm.TF.7">
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
                </fn>
                <fn id="mfm.TF.7.1">
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product</bold>. BAG family molecular chaperone regulator 3 (Bag3) is a co-chaperone for the Z-disk and has anti-apoptotic properties. It has 575 amino acid residues.</p>
            <p><bold>Abnormal gene product</bold>. Mutant Bag3 may alter the folding of Bag3 or may allosterically affect the binding properties of the canonical Bag3 domains.</p>
          </sec>
          <sec id="mfm.FHL1">
            <title>
              <italic toggle="yes">FHL1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">FHL1</italic> has three alternatively spliced transcript variants that encode different protein isoforms with different tissue localizations and protein interactions. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mfm" object-id="mfm.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> Selected reports of mutations include <xref ref-type="bibr" rid="mfm.REF.quinzii.2008.208">Quinzii et al [2008]</xref>, <xref ref-type="bibr" rid="mfm.REF.schessl.2008.904">Schessl et al [2008]</xref>, <xref ref-type="bibr" rid="mfm.REF.windpassinger.2008.88">Windpassinger et al [2008]</xref>, <xref ref-type="bibr" rid="mfm.REF.selcen.2011.1951">Selcen et al [2011]</xref>.</p>
            <p><bold>Normal gene product.</bold> FHL1 is a Z-disk related protein and some of its isoforms shuttle between cytoplasm and nucleus.</p>
            <p><bold>Abnormal gene product.</bold> Not known; likely dominant-negative effect.</p>
          </sec>
          <sec id="mfm.DNAJB6">
            <title>
              <italic toggle="yes">DNAJB6</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">DNAJB6</italic> has published two alternatively spliced transcript variants that encode different protein isoforms. The longer transcript variant, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_058246.3">NM_058246.3</ext-link>, has ten exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mfm" object-id="mfm.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> Mutations have been reported [<xref ref-type="bibr" rid="mfm.REF.harms.2012.407">Harms et al 2012</xref>, <xref ref-type="bibr" rid="mfm.REF.sarparanta.2012.450">Sarparanta et al 2012</xref>].</p>
            <p><bold>Normal gene product.</bold> The transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_005494.2">NM_005494.2</ext-link> encodes a protein isoform with 241 amino acid residues (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_005485.1">NP_005485.1</ext-link>). DnaJ homolog subfamily B member 6 (DNAJB6) is a member of heat shock protein family with molecular chaperone function.</p>
            <p><bold>Abnormal gene product</bold>. In vitro studies demonstrated that the missense mutations increase the half-life of DNAJB6 and reduce its anti-aggregation effect [<xref ref-type="bibr" rid="mfm.REF.sarparanta.2012.450">Sarparanta et al 2012</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="mfm.References">
        <title>References</title>
        <sec id="mfm.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="mfm.Literature_Cited.reflist0">
            <ref id="mfm.REF.abraham.1998.876">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abraham</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeNofrio</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loh</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minda</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomaszewski</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietra</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynolds</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Desmin myopathy involving cardiac, skeletal, and vascular smooth muscle: report of a case with immunoelectron microscopy.</article-title>
                <source>Hum Pathol.</source>
                <year>1998</year>
                <volume>29</volume>
                <fpage>876</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">9712432</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.arbustini.1998.645">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arbustini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morbini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grasso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fasani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verga</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellini</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dal Bello</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campana</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccolo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Febo</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opasich</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gavazzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrans</surname>
                    <given-names>VJ</given-names>
                  </name>
                </person-group>
                <article-title>Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits.</article-title>
                <source>J Am Coll Cardiol.</source>
                <year>1998</year>
                <volume>31</volume>
                <fpage>645</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">9502648</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.bar.2006.1031">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>B&#x000e4;r</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;cke</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ringler</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kreplak</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katus</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aebi</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herrmann</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Impact of disease mutations on the desmin filament assembly process.</article-title>
                <source>J Mol Biol.</source>
                <year>2006</year>
                <volume>360</volume>
                <fpage>1031</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">16828798</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.calderon.1987.108">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Calderon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>EG</given-names>
                  </name>
                </person-group>
                <article-title>Subsarcolemmal vermiform deposits in skeletal muscle, associated with familial cardiomyopathy: report of two cases of a new entity.</article-title>
                <source>Pediatr Neurosci.</source>
                <year>1987</year>
                <volume>13</volume>
                <fpage>108</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">3438215</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.capetanaki.1997.103">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Capetanaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milner</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weitzer</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Desmin in muscle formation and maintenance: knockouts and consequences.</article-title>
                <source>Cell Struct Funct.</source>
                <year>1997</year>
                <volume>22</volume>
                <fpage>103</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">9113396</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.clark.1978.399">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Agostino</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <etal/>
                <article-title>Autosomal dominant myofibrillar inclusion body myopathy: clinical, histologic, histochemical, and ultrastructural characteristics.</article-title>
                <source>Neurology</source>
                <year>1978</year>
                <volume>28</volume>
                <fpage>399</fpage>
              </element-citation>
            </ref>
            <ref id="mfm.REF.dalakas.2000.770">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dalakas</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>KY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semino-Mora</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sivakumar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldfarb</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <article-title>Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene.</article-title>
                <source>N Engl J Med.</source>
                <year>2000</year>
                <volume>342</volume>
                <fpage>770</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">10717012</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.debleecker.1996.563">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Bleecker</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ertl</surname>
                    <given-names>BB</given-names>
                  </name>
                </person-group>
                <article-title>Myofibrillar myopathy with abnormal foci of desmin positivity. II. Immunocytochemical analysis reveals accumulation of multiple other proteins.</article-title>
                <source>J Neuropathol Exp Neurol.</source>
                <year>1996</year>
                <volume>55</volume>
                <fpage>563</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">8627347</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.delbigio.2011.866">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Del Bigio</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chudley</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarnat</surname>
                    <given-names>HB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goobie</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chodirker</surname>
                    <given-names>BN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Infantile muscular dystrophy in Canadian aboriginals is an &#x003b1;B-crystallinopathy.</article-title>
                <source>Ann Neurol.</source>
                <year>2011</year>
                <volume>69</volume>
                <fpage>866</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">21337604</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.edstrom.1980.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Edstr&#x000f6;m</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thornell</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eriksson</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>A new type of hereditary distal myopathy with characteristic sarcoplasmic bodies and intermediate (skeletin) filaments.</article-title>
                <source>J Neurol Sci.</source>
                <year>1980</year>
                <volume>47</volume>
                <fpage>171</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">6251174</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.fardeau.1978.411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godet-Guillain</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tome</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaudeau</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boffety</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vernant</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <source>Rev Neurol (Paris)</source>
                <year>1978</year>
                <volume>134</volume>
                <fpage>411</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">570292</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.fidzianska.1983.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fidzianska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osborn</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenard</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osse</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langenbeck</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <article-title>Mallory body-like inclusions in a hereditary congenital neuromuscular disease.</article-title>
                <source>Muscle Nerve.</source>
                <year>1983</year>
                <volume>6</volume>
                <fpage>195</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">6343859</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.fischer.2006.361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clemen</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliv&#x000e9;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goudeau</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roth</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Badorf</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wattjes</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lutterbey</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kral</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Ven</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>F&#x000fc;rst</surname>
                    <given-names>DO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vicart</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldfarb</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moza</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpen</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichelt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schr&#x000f6;der</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Different early pathogenesis in myotilinopathy compared to primary desminopathy.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2006</year>
                <volume>16</volume>
                <fpage>361</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16684602</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.forrest.2011.37">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Forrest</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Sarraj</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buk</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pitt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durward</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDougall</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irving</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarkozy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barresi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wraige</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Infantile onset myofibrillar myopathy due to recessive CRYAB mutations.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2011</year>
                <volume>21</volume>
                <fpage>37</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">21130652</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.garvey.2006.2348">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garvey</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claflin</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faulkner</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>Transgenic mice expressing the myotilin T57I mutation unite the pathology associated with LGMD1A and MFM.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2006</year>
                <volume>15</volume>
                <fpage>2348</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">16801328</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.goebel.1978.14">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillen</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merritt</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant "spheroid body myopathy."</article-title>
                <source>Muscle Nerve</source>
                <year>1978</year>
                <volume>1</volume>
                <fpage>14</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">571956</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.goebel.1997.426">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <article-title>Desmin-related myopathies.</article-title>
                <source>Curr Opin Neurol</source>
                <year>1997</year>
                <volume>10</volume>
                <fpage>426</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9330890</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.goldfarb.1998.402">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldfarb</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>KY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerven&#x000e1;kov&#x000e1;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorokhova</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasconcelos</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagle</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semino-Mora</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sivakumar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalakas</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <article-title>Missense mutations in desmin associated with familial cardiac and skeletal myopathy.</article-title>
                <source>Nat Genet.</source>
                <year>1998</year>
                <volume>19</volume>
                <fpage>402</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">9697706</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.goldfarb.2004.723">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldfarb</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vicart</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalakas</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <article-title>Desmin myopathy.</article-title>
                <source>Brain.</source>
                <year>2004</year>
                <volume>127</volume>
                <fpage>723</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">14724127</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.harms.2012.407">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harms</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sommerville</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allred</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopate</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pestronk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weihl</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <article-title>Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy.</article-title>
                <source>Ann Neurol.</source>
                <year>2012</year>
                <volume>71</volume>
                <fpage>407</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">22334415</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.hauser.2002.1428">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conde</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowaljow</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeppa</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taratuto</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torian</surname>
                    <given-names>UM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pericak-Vance</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speer</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosa</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <article-title>myotilin Mutation found in second pedigree with LGMD1A.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2002</year>
                <volume>71</volume>
                <fpage>1428</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">12428213</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.hauser.2000.2141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horrigan</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salmikangas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torian</surname>
                    <given-names>UM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viles</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dancel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tim</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taivainen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartoloni</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilchrist</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stajich</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaskell</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilbert</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pericak-Vance</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpen</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westbrook</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speer</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <article-title>Myotilin is mutated in limb girdle muscular dystrophy 1A.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2000</year>
                <volume>9</volume>
                <fpage>2141</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10958653</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.horowitz.1994.151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horowitz</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmalbruch</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant distal myopathy with desmin storage: a clinicopathologic and electrophysiologic study of a large kinship.</article-title>
                <source>Muscle Nerve.</source>
                <year>1994</year>
                <volume>17</volume>
                <fpage>151</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">8114783</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.kinoshita.1975.417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kinoshita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satoyoshi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>Atypical myopathy with myofibrillar aggregates.</article-title>
                <source>Arch Neurol.</source>
                <year>1975</year>
                <volume>32</volume>
                <fpage>417</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">165803</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.lobrinus.1998.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lobrinus</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janzer</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuntzer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthieu</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfend</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goy</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bogousslavsky</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Familial cardiomyopathy and distal myopathy with abnormal desmin accumulation and migration.</article-title>
                <source>Neuromuscul Disord</source>
                <year>1998</year>
                <volume>8</volume>
                <fpage>77</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">9608560</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.luan.2010.390">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luan</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hong</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>A novel heterozygous deletion-insertion mutation (2695-2712 del/GTTTGT ins) in exon 18 of the filamin C gene causes filaminopathy in a large Chinese family.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2010</year>
                <volume>20</volume>
                <fpage>390</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20417099</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.luan.2010.390.Literature_Cit.27">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luan</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hong</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>A novel heterozygous deletion-insertion mutation (2695-2712 del/GTTTGT ins) in exon 18 of the filamin C gene causes filaminopathy in a large Chinese family.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2010</year>
                <volume>20</volume>
                <fpage>390</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20417099</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.munozmarmol.1998.11312">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Munoz-Marmol</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strasser</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isamat</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coulombe</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roca</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vela</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mate</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coll</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez-Figueras</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navas-Palacios</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ariza</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuchs</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>A dysfunctional desmin mutation in a patient with severe generalized myopathy.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <year>1998</year>
                <volume>95</volume>
                <fpage>11312</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9736733</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.nakano.1997.850">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiguchi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Myofibrillar myopathy. III. Abnormal expression of cyclin-dependent kinases and nuclear proteins.</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <year>1997</year>
                <volume>56</volume>
                <fpage>850</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9258254</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.nakashima.1970.270">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakashima</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okamoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Inclusion bodies in human neuromuscular disorder.</article-title>
                <source>Arch Neurol.</source>
                <year>1970</year>
                <volume>22</volume>
                <fpage>270</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">5411681</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.penissonbesnier.2006.427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Penisson-Besnier</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talvinen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dumez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vihola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hackman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpen</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B.</given-names>
                  </name>
                </person-group>
                <article-title>Myotilinopathy in a family with late onset myopathy.</article-title>
                <source>Neuromuscul Disord</source>
                <year>2006</year>
                <volume>16</volume>
                <fpage>427</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">16793270</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.quinzii.2008.208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Quinzii</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vu</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Min</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanji</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barral</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grewal</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kattah</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cama&#x000f1;o</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otaegui</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunimatsu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blake</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilhelmsen</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rowland</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hays</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2008</year>
                <volume>82</volume>
                <fpage>208</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">18179901</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.sabatelli.1992.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sabatelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salviati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papacci</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonali</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>Peripheral neuropathy with giant axons and cardiomyopathy associated with desmin type intermediate filaments in skeletal muscle.</article-title>
                <source>J Neurol Sci</source>
                <year>1992</year>
                <volume>109</volume>
                <fpage>1</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">1517757</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.sarparanta.2012.450">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sarparanta</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonson</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golzio</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luque</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Screen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDonald</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stajich</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahjneh</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vihola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raheem</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penttil&#x000e4;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehtinen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huovinen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmio</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasca</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hackman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katsanis</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.</article-title>
                <source>Nat Genet.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>450</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22366786</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.schessl.2008.904">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schessl</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zou</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowling</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maiti</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chin</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cottle</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spruce</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganguly</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Judkins</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golden</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanigan</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;nnemann</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <article-title>Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy.</article-title>
                <source>J Clin Invest.</source>
                <year>2008</year>
                <volume>118</volume>
                <fpage>904</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">18274675</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.selcen.2011.1951">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bromberg</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chin</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <article-title>Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy.</article-title>
                <source>Neurology.</source>
                <year>2011</year>
                <volume>77</volume>
                <fpage>1951</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22094483</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.selcen.2004.1363">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in myotilin cause myofibrillar myopathy.</article-title>
                <source>Neurology</source>
                <year>2004</year>
                <volume>62</volume>
                <fpage>1363</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">15111675</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.selcen.2005.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in ZASP define a novel form of muscular dystrophy in humans.</article-title>
                <source>Ann Neurol</source>
                <year>2005</year>
                <volume>57</volume>
                <fpage>269</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">15668942</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.selcen.2003.804">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <article-title>Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations.</article-title>
                <source>Ann Neurol</source>
                <year>2003</year>
                <volume>54</volume>
                <fpage>804</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">14681890</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.selcen.2009.83">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burton</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pegoraro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bite</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <article-title>Mutation in BAG3 causes severe dominant childhood muscular dystrophy.</article-title>
                <source>Ann Neurol</source>
                <year>2009</year>
                <volume>65</volume>
                <fpage>83</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19085932</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.selcen.2004.439">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <article-title>Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients.</article-title>
                <source>Brain</source>
                <year>2004</year>
                <volume>127</volume>
                <fpage>439</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">14711882</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.shatunov.2009.656">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shatunov</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliv&#x000e9;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odgerel</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stadelmann-Nessler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irlbacher</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Landeghem</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayarsaikhan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goudeau</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilton-Jones</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damian</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaminska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vicart</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalakas</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sambuughin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldfarb</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <article-title>In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy.</article-title>
                <source>Eur J Hum Genet</source>
                <year>2009</year>
                <volume>17</volume>
                <fpage>656</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">19050726</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.vicart.1998.92">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vicart</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caron</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prevost</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faure</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chateau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tome</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupret</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paulin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy.</article-title>
                <source>Nat Genet</source>
                <year>1998</year>
                <volume>20</volume>
                <fpage>92</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9731540</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.vorgerd.2005.297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vorgerd</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Ven</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruchertseifer</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lowe</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kley</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schroder</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Himmel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koehler</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furst</surname>
                    <given-names>DO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huebner</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy.</article-title>
                <source>Am J Hum Genet</source>
                <year>2005</year>
                <volume>77</volume>
                <fpage>297</fpage>
                <lpage>304</lpage>
                <pub-id pub-id-type="pmid">15929027</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.wang.2001.84">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osinska</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klevitsky</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerdes</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nieman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hewett</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robbins</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice.</article-title>
                <source>Circ Res.</source>
                <year>2001</year>
                <volume>89</volume>
                <fpage>84</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">11440982</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.windpassinger.2008.88">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Windpassinger</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoser</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hochmeister</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noor</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohberger</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farra</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwarzbraun</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ofner</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;scher</surname>
                    <given-names>WN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quasthoff</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2008</year>
                <volume>82</volume>
                <fpage>88</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">18179888</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.wolburg.1982.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolburg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlote</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langohr</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peiffer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reiher</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heckl</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <article-title>Slowly progressive congenital myopathy with cytoplasmic bodies--report of two cases and a review of the literature.</article-title>
                <source>Clin Neuropathol</source>
                <year>1982</year>
                <volume>1</volume>
                <fpage>55</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">6301720</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="mfm.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="mfm.Suggested_Reading.reflist0">
            <ref id="mfm.REF.olive.2009.507">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oliv&#x000e9;</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Extralysosomal protein degradation in myofibrillar myopathies.</article-title>
                <source>Brain Pathol</source>
                <year>2009</year>
                <volume>19</volume>
                <fpage>507</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">19563542</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.piiolripoll.2009.418">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pi&#x000f1;ol-Ripoll</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shatunov</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larrod&#x000e9;</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Puerta</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelegr&#x000ed;n</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramos</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliv&#x000e9;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldfarb</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <source>Neuromuscul Disord</source>
                <year>2009</year>
                <volume>19</volume>
                <fpage>418</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">19433360</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.schroder.2009.483">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schroder</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoser</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Myofibrillar myopathies: a clinical and myopathological guide.</article-title>
                <source>Brain Pathol</source>
                <year>2009</year>
                <volume>19</volume>
                <fpage>483</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">19563540</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.selcen.2008.585">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Myofibrillar myopathies.</article-title>
                <source>Curr Opin Neurol</source>
                <year>2008</year>
                <volume>21</volume>
                <fpage>585</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18769253</pub-id>
              </element-citation>
            </ref>
            <ref id="mfm.REF.shalaby.2009.701">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shalaby</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsuhashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuda</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minami</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noguchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>YK</given-names>
                  </name>
                </person-group>
                <source>J Neuropathol Exp Neurol</source>
                <year>2009</year>
                <volume>68</volume>
                <fpage>701</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19458539</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="mfm.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="mfm.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>29 October 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>27 July 2010 (cd) Revision: sequence analysis for <italic toggle="yes">BAG3</italic> mutations available clinically</p>
            </list-item>
            <list-item>
              <p>2 February 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>10 March 2008 (cd) Revision: sequence analysis and prenatal diagnosis available clinically for zaspopathy <italic toggle="yes">(LDB3</italic> mutations)</p>
            </list-item>
            <list-item>
              <p>1 March 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>9 January 2006 (ds) Revision: included disorders added (zaspopathy, filaminopathy)</p>
            </list-item>
            <list-item>
              <p>1 July 2005 (ds) Revision: <italic toggle="yes">DES</italic> testing clinically available</p>
            </list-item>
            <list-item>
              <p>28 January 2005 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>2 August 2004 (ds) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="mfm.1.12" sec-type="figs-and-tables">
        <title/>
        <fig id="mfm.F1" position="float" orientation="portrait">
          <label>Figure 1.</label>
          <caption>
            <p>Muscle histology observed in myofibrillar myopathy</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mfmFig1" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
